鱼跃医疗
(002223)
| 流通市值：246.14亿 | | | 总市值：261.99亿 |
| 流通股本：9.34亿 | | | 总股本：9.95亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 4,569,315,559.46 | 2,370,366,154.18 | 7,955,022,614.76 | 6,544,895,742.68 |
| 营业总成本 | 3,668,138,104.59 | 1,866,982,526.48 | 6,616,589,598.1 | 5,187,824,391.82 |
| 其他经营收益 | | | | |
| 营业利润 | 958,139,904.82 | 501,292,729 | 1,700,320,952.34 | 1,685,030,326.08 |
| 利润总额 | 971,604,908.29 | 501,402,173.47 | 1,684,492,195.65 | 1,684,332,877.45 |
| 净利润 | 847,869,043.23 | 429,211,239.02 | 1,484,136,250.87 | 1,466,298,649.79 |
| 每股收益 | | | | |
| 其他综合收益 | -28,429,681.41 | -21,770,602.63 | 98,208,788.57 | -25,254,882.74 |
| 综合收益总额 | 819,439,361.82 | 407,440,636.39 | 1,582,345,039.44 | 1,441,043,767.05 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 8,743,989,551.99 | 6,633,656,957.5 | 3,797,199,703.35 | 10,223,791,620.85 |
| 非流动资产: | | | | |
| 非流动资产合计 | 8,156,819,903.42 | 10,255,578,377.03 | 12,287,065,321.34 | 6,447,449,482.28 |
| 资产总计 | 16,900,809,455.41 | 16,889,235,334.53 | 16,084,265,024.69 | 16,671,241,103.13 |
| 流动负债: | | | | |
| 流动负债合计 | 3,169,648,467.1 | 2,825,540,893.99 | 2,458,668,934.67 | 2,768,309,795.86 |
| 非流动负债: | | | | |
| 非流动负债合计 | 281,380,371.97 | 299,742,381.75 | 270,390,583.16 | 267,726,475.98 |
| 负债合计 | 3,451,028,839.07 | 3,125,283,275.74 | 2,729,059,517.83 | 3,036,036,271.84 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 13,332,044,850.99 | 13,650,005,211.78 | 13,240,967,251.92 | 13,521,175,567.81 |
| 股东权益合计 | 13,449,780,616.34 | 13,763,952,058.79 | 13,355,205,506.86 | 13,635,204,831.29 |
| 负债和股东权益合计 | 16,900,809,455.41 | 16,889,235,334.53 | 16,084,265,024.69 | 16,671,241,103.13 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 4,966,033,996.85 | 2,506,674,223.26 | 9,008,754,158.81 | 7,146,382,148.93 |
| 经营活动现金流出小计 | 3,783,875,585.01 | 1,909,562,786.79 | 7,505,832,443.02 | 5,642,881,477.48 |
| 经营活动产生的现金流量净额 | 1,182,158,411.84 | 597,111,436.47 | 1,502,921,715.79 | 1,503,500,671.45 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 883,418,909.55 | 8,280,162 | 141,416,770.69 | 140,748,706.07 |
| 投资活动现金流出小计 | 500,664,473 | 206,623,653.99 | 6,793,439,139.87 | 373,222,771.81 |
| 投资活动产生的现金流量净额 | 382,754,436.55 | -198,343,491.99 | -6,652,022,369.18 | -232,474,065.74 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | 5,336,538.8 | - | 9,701,657.1 |
| 筹资活动现金流出小计 | 741,001,825.42 | 7,367,804.14 | 821,817,705.99 | 412,423,212.99 |
| 筹资活动产生的现金流量净额 | -741,001,825.42 | -2,031,265.34 | -821,817,705.99 | -402,721,555.89 |
| 汇率变动对现金及现金等价物的影响 | -42,434,176.04 | -34,154,362.67 | -51,975,920.09 | -21,220,102.32 |
| 现金及现金等价物净增加额 | 781,476,846.93 | 362,582,316.47 | -6,022,894,279.47 | 847,084,947.5 |
| 期末现金及现金等价物余额 | 1,354,580,976.38 | 935,686,445.92 | 573,104,129.45 | 7,443,083,356.42 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 781,476,846.93 | - | -6,022,894,279.47 | - |
最新报告期：2026-09-29| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华创证券 | 郑辰,李婵娟,陈俊威 | 1.55 | 1.73 | 1.95 | 2026-09-29 |
| 华源证券 | 刘闯 | 1.60 | 1.80 | 2.07 | 2026-09-07 |
| 平安证券 | 叶寅,倪亦道,裴晓鹏 | 1.54 | 1.70 | 1.92 | 2026-08-26 |
| 兴业证券 | 孙媛媛,董晓洁,黄翰漾 | 1.53 | 1.74 | 2.00 | 2026-08-26 |
| 东吴证券 | 朱国广 | 1.47 | 1.67 | 1.83 | 2026-08-25 |